PrashantKumar Khirsariya, Ph.D., M.Sc.
výzkumník II – Ústav chemie
Počet publikací: 28
2018
-
Selective CHK1 inhibitor MU380 exhibits single-agent activity against chronic lymphocytic leukemia cells with TP53 mutations
Rok: 2018, druh: Konferenční abstrakty
2017
-
Diastereoselective Flexible Synthesis of Carbocyclic C Nucleosides
The Journal of Organic Chemistry, rok: 2017, ročník: 82, vydání: 7, DOI
-
Flow cytometric analysis of nucleoside transporters activity
Rok: 2017, druh: Konferenční abstrakty
-
Chk1 Inhibitor SCH900776 Effectively Potentiates the Cytotoxic Effects of Platinum-Based Chemotherapeutic Drugs in Human Colon Cancer Cells
Neoplasia, rok: 2017, ročník: 19, vydání: 10, DOI
-
Structural Basis of the Interaction of Cyclin-Dependent Kinase 2 with Roscovitine and Its Analogues Having Bioisosteric Central Heterocycles
ChemPhysChem, rok: 2017, ročník: 18, vydání: 7, DOI
-
Synthesis and Profiling of a Novel Potent Selective Inhibitor of CHK1 Kinase Possessing Unusual N-trifluoromethylpyrazole Pharmacophore Resistant to Metabolic N-dealkylation
Molecular Cancer Therapeutics, rok: 2017, ročník: 16, vydání: 9, DOI
2016
-
Development and validation of a highly sensitive LC-MS method for determination of checkpoint kinase 1 inhibitors in mouse plasma
Advances in chromatography and electrophoresis & Chiranal 2016, rok: 2016
2015
-
Chronic lymphocytic leukemia cells are highly susceptible to direct inhibition of checkpoint kinase
Rok: 2015, druh: Konferenční abstrakty